mRNA Therapy Helps Damaged Hearts Pump 10% More
mRNA Therapy Helps Damaged Hearts Pump 10% More
mRNA Therapy Helps Damaged Hearts Pump 10% More
Key points
اہم نکات
मुख्य बातें
- An experimental mRNA therapy helped damaged mouse hearts pump about 10 percent more blood with each beat, raising hopes of a treatment that repairs the heart after a heart attack.
- Scientists at the University of Cambridge, writing in Nature Cardiovascular Research on November 9, used mRNA to briefly switch on two proteins, Myc and Cyclin T1, waking dormant heart muscle cells so they divide and replace scarred tissue.
- The treated hearts also gained 14 to 16 percent in pumping efficiency, and the gains lasted at least 12 weeks.
- An experimental mRNA therapy helped damaged mouse hearts pump about 10 percent more blood with each beat, raising hopes of a treatment that repairs the heart after a heart attack.
- Scientists at the University of Cambridge, writing in Nature Cardiovascular Research on November 9, used mRNA to briefly switch on two proteins, Myc and Cyclin T1, waking dormant heart muscle cells so they divide and replace scarred tissue.
- The treated hearts also gained 14 to 16 percent in pumping efficiency, and the gains lasted at least 12 weeks.
- An experimental mRNA therapy helped damaged mouse hearts pump about 10 percent more blood with each beat, raising hopes of a treatment that repairs the heart after a heart attack.
- Scientists at the University of Cambridge, writing in Nature Cardiovascular Research on November 9, used mRNA to briefly switch on two proteins, Myc and Cyclin T1, waking dormant heart muscle cells so they divide and replace scarred tissue.
- The treated hearts also gained 14 to 16 percent in pumping efficiency, and the gains lasted at least 12 weeks.
An experimental mRNA therapy helped damaged mouse hearts pump about 10 percent more blood with each beat, raising hopes of a treatment that repairs the heart after a heart attack. Scientists at the University of Cambridge, writing in Nature Cardiovascular Research on November 9, used mRNA to briefly switch on two proteins, Myc and Cyclin T1, waking dormant heart muscle cells so they divide and replace scarred tissue. The treated hearts also gained 14 to 16 percent in pumping efficiency, and the gains lasted at least 12 weeks. The work is still early, with larger animals and then human trials needed before it can help patients.
An experimental mRNA therapy helped damaged mouse hearts pump about 10 percent more blood with each beat, raising hopes of a treatment that repairs the heart after a heart attack. Scientists at the University of Cambridge, writing in Nature Cardiovascular Research on November 9, used mRNA to briefly switch on two proteins, Myc and Cyclin T1, waking dormant heart muscle cells so they divide and replace scarred tissue. The treated hearts also gained 14 to 16 percent in pumping efficiency, and the gains lasted at least 12 weeks. The work is still early, with larger animals and then human trials needed before it can help patients.
An experimental mRNA therapy helped damaged mouse hearts pump about 10 percent more blood with each beat, raising hopes of a treatment that repairs the heart after a heart attack. Scientists at the University of Cambridge, writing in Nature Cardiovascular Research on November 9, used mRNA to briefly switch on two proteins, Myc and Cyclin T1, waking dormant heart muscle cells so they divide and replace scarred tissue. The treated hearts also gained 14 to 16 percent in pumping efficiency, and the gains lasted at least 12 weeks. The work is still early, with larger animals and then human trials needed before it can help patients.
Most read
سب سے زیادہ پڑھی گئی
सबसे ज़्यादा पढ़ी गई
- Loading...
Get news in your inbox
خبریں اپنے ان باکس میں حاصل کریں
खबरें अपने इनबॉक्स में पाएं
One email when new stories are published. No spam, unsubscribe anytime.
نئی خبریں شائع ہونے پر ایک ای میل۔ کوئی سپیم نہیں، کسی بھی وقت ان سبسکرائب کریں۔
नई खबरें प्रकाशित होने पर एक ईमेल। कोई स्पैम नहीं, कभी भी अनसब्सक्राइब करें।